The "TET2 Gene Myelodysplastic Syndrome Somatic Genetic Test" is a specialized diagnostic tool used to identify mutations in the TET2 gene, which are often associated with myelodysplastic syndromes (MDS). Myelodysplastic syndromes are a group of bone marrow disorders characterized by the bone marrow's inability to produce enough healthy blood cells. Mutations in the TET2 gene can influence the development and progression of these conditions, making this test a critical component in the diagnosis and management of MDS.
Conducted at DNA Labs UAE, the test involves analyzing the patient's DNA to detect any abnormalities or mutations in the TET2 gene that might contribute to the disease. This information is crucial for determining the most appropriate treatment plan for individuals with MDS. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed to achieve accurate results.
Overall, the TET2 Gene Myelodysplastic Syndrome Somatic Genetic Test is an invaluable resource for healthcare providers in the diagnosis and treatment of myelodysplastic syndromes, offering insights that can significantly impact patient care and outcomes.
The JAK2 Gene Myelofibrosis Somatic Genetic Test is a specialized diagnostic assessment designed to detect mutations in the JAK2 gene, which are commonly associated with myelofibrosis, a type of chronic blood cancer. This test is crucial for the accurate diagnosis and management of myelofibrosis, as the presence of JAK2 mutations can influence treatment decisions and prognosis. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis to identify the specific genetic alterations in the JAK2 gene. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to perform this sophisticated examination. By identifying JAK2 mutations, healthcare providers can tailor treatment strategies more effectively, improving patient outcomes in managing myelofibrosis.
The PRKAR1A Gene Myxoma Intracardiac Genetic Test is a specialized diagnostic tool used to identify mutations in the PRKAR1A gene, which are associated with cardiac myxoma, a type of heart tumor. This test is crucial for patients with a family history of cardiac myxoma or those presenting symptoms suggestive of this condition, as it helps in confirming the diagnosis and guiding treatment decisions. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the PRKAR1A gene to detect any genetic anomalies that could predispose an individual to developing intracardiac myxomas. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the gene of interest. This genetic test is a valuable resource for both patients and healthcare providers, enabling early detection and personalized management of cardiac myxomas.
The NF1 Gene Neurofibromatosis Type 1 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, aimed at detecting mutations in the NF1 gene, which is responsible for neurofibromatosis type 1 (NF1). NF1 is a genetic disorder characterized by the growth of noncancerous tumors along the nerves in the skin, brain, and other parts of the body. It is an autosomal dominant disorder, meaning a mutation in just one of the two copies of the gene in each cell is sufficient to cause the condition.
This genetic test involves analyzing the patient's DNA to identify mutations in the NF1 gene that are known to cause the disorder. The process helps in confirming a diagnosis of neurofibromatosis type 1, which can be crucial for early intervention and management of the condition. It also aids in genetic counseling for families, providing them with information on the risk of passing the disorder to future generations.
The cost of the NF1 Gene Neurofibromatosis Type 1 Genetic Test at DNA Labs UAE is 4400 AED. The test is conducted in a state-of-the-art facility by experienced geneticists and laboratory technicians, ensuring high accuracy and reliability of the results. Patients opting for this test at DNA Labs UAE can expect professional service, confidentiality, and comprehensive support throughout the testing process.
The SPRED1 Gene Neurofibromatosis Type 1-Like Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SPRED1 gene, which are associated with Legius syndrome, a condition that closely resembles Neurofibromatosis Type 1 (NF1). Legius syndrome, also known as Neurofibromatosis Type 1-like syndrome, presents with similar clinical features to NF1, including café-au-lait spots and freckling, but lacks the tumor predisposition seen in NF1. This genetic test plays a crucial role in differentiating between these two conditions, enabling accurate diagnosis and personalized management plans for affected individuals.
The test involves a detailed analysis of the SPRED1 gene, looking for specific genetic alterations that confirm the diagnosis of Legius syndrome. This process aids healthcare providers in making informed decisions about the patient's condition, avoiding unnecessary interventions associated with the misdiagnosis of NF1, and providing targeted clinical surveillance for complications that may arise from the syndrome.
The cost of the SPRED1 Gene Neurofibromatosis Type 1-Like Syndrome Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this test, the price reflects the sophisticated technology and expertise required to accurately identify mutations in the SPRED1 gene. Patients seeking this test can expect a high standard of accuracy and reliability from DNA Labs UAE, a facility known for its state-of-the-art genetic testing services.
The NF2 Gene Neurofibromatosis Type 2 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the NF2 gene, which is crucial for diagnosing Neurofibromatosis Type 2 (NF2). NF2 is a rare genetic disorder characterized by the growth of noncancerous tumors in the nervous system, especially in the brain and spinal cord. Early diagnosis through genetic testing can be pivotal in managing and treating the condition effectively.
This test is conducted by extracting a DNA sample, typically through a blood draw, and then analyzing the specific segments of the NF2 gene for any abnormalities or mutations that are known to cause the disorder. It is a crucial step for individuals with a family history of NF2 or those showing symptoms suggestive of the disease, as it provides a definitive diagnosis.
The cost of the NF2 Gene Neurofibromatosis Type 2 Genetic Test is set at 4400 AED and is available at DNA Labs UAE. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals experienced in genetic diagnostics, ensuring accurate and reliable test results. Opting for this test at DNA Labs UAE not only offers individuals a chance for early detection but also guides healthcare professionals in tailoring a management and treatment plan specific to the genetic makeup of the patient's condition.
The PMS1 gene nonpolyposis hereditary colon cancer, also known as Lynch syndrome, is a condition characterized by a significantly increased risk of developing colon cancer and other types of cancer, often at a younger age than typically observed in the general population. The condition is inherited in an autosomal dominant manner, meaning that a mutation in just one of the two copies of the PMS1 gene is sufficient to increase an individual's cancer risk.
The PMS1 related genetic test is a specific diagnostic tool designed to identify mutations in the PMS1 gene that are associated with this increased cancer risk. By analyzing an individual's DNA, the test can help determine whether they have inherited a mutation that predisposes them to Lynch syndrome. This information is crucial for both the individual and their family members, as it can guide healthcare professionals in recommending appropriate surveillance and preventive measures to manage the increased cancer risk.
The test is offered at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost of the PMS1 related genetic test is 4400 AED. Opting for this test at DNA Labs UAE ensures that individuals receive accurate and reliable results, which are essential for making informed decisions about their health and cancer risk management.
The EGFR Gene Non-Small Cell Lung Cancer Familial Susceptibility Genetic Test is a comprehensive diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the EGFR gene that are associated with an increased risk of developing non-small cell lung cancer (NSCLC). This particular form of lung cancer is the most common type, accounting for about 85% of all lung cancer cases. The EGFR gene plays a crucial role in cell growth and division; mutations in this gene can lead to uncontrolled cell proliferation, often resulting in cancer.
Familial susceptibility to NSCLC means that individuals with specific genetic alterations in the EGFR gene are at a higher risk of developing the disease, potentially at an earlier age than the general population. This test is particularly valuable for individuals with a family history of lung cancer, as it can help identify those who carry these genetic mutations and are therefore at an increased risk.
The test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for the presence of mutations in the EGFR gene.
The cost of the EGFR Gene Non-Small Cell Lung Cancer Familial Susceptibility Genetic Test is 4400 AED. Although the price may seem steep, the information gained from this test can be invaluable for at-risk individuals and their families. It can guide decision-making regarding early surveillance, preventive measures, or even treatment options in the event of a cancer diagnosis. Early detection and intervention are key factors in improving outcomes for those with a familial risk of NSCLC, making this test a crucial step for those with a significant family history of lung cancer.
The "NPM1 Gene NPM1 Selective Sequencing of Exon 11 Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in exon 11 of the NPM1 gene. This gene plays a crucial role in the proper functioning of cells, including processes related to cell division, growth, and apoptosis. Mutations in exon 11 of the NPM1 gene are particularly significant as they are often associated with certain types of leukemia, including acute myeloid leukemia (AML), making this test an important tool in the diagnosis and management of patients with or at risk of developing such conditions.
The test involves sequencing the specific region of the NPM1 gene to identify any genetic alterations. This information can be critical for determining the prognosis of patients with leukemia, influencing treatment decisions, and monitoring response to therapy. Given its importance in the clinical setting, the test is meticulously conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability of results.
The cost of the "NPM1 Gene NPM1 Selective Sequencing of Exon 11 Genetic Test" at DNA Labs UAE is 4400 AED. This price reflects the complexity of the testing process and the significant value it provides in the clinical diagnosis and management of diseases associated with mutations in the NPM1 gene. Patients and healthcare providers considering this test can expect a high level of service and support from DNA Labs UAE, a reputable institution in the field of genetic testing and analysis.
The NRAS Gene NRAS Selective Sequencing of Exons 2 and 3 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to scrutinize the NRAS gene, particularly focusing on exons 2 and 3. These specific regions of the gene are critical because mutations in these exons are often implicated in various forms of cancer, including melanoma, colorectal cancer, and certain types of leukemia. By selectively sequencing these exons, healthcare providers can gain valuable insights into the genetic underpinnings of a patient's condition, facilitating personalized treatment plans that are more effective and targeted.
The test is priced at 4400 AED and is performed in the state-of-the-art facilities of DNA Labs UAE. It involves collecting a DNA sample from the patient, which is then analyzed using advanced sequencing technologies to identify any mutations or abnormalities in the specified exons of the NRAS gene. This information is crucial for predicting disease progression, determining the likelihood of developing certain types of cancer, and selecting the most appropriate therapeutic interventions. Given the precision and specialized nature of this test, it represents a significant tool in the arsenal of modern medicine for managing and treating cancer with a genetic component.
